Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drospirenone-only vs drospirenone + ethinyl estradiol in PCOS hyperandrogenism
TCTR20260211001Phase 3Not yet recruiting
- Sponsor
- Mahidol University
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of drospirenone, ethinyl estradiol in polycystic ovary syndrome (PCOS), sponsored by Mahidol University. Planned start May 2026; status: not yet recruiting.
02
Drugs
drospirenoneethinyl estradiol
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on TCTR20260211001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260211001.